Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01937949 · ClinicalTrials.gov registry record · NA
Complex Abdominal Aortic Aneurysm Repair With Fenestrated Stent Grafts
A NA study of Juxtarenal Aortic Aneurysms and Suprarenal Aortic Aneurysms, sponsored by Gustavo S Oderich.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT01937949: Recruiting NA study of Juxtarenal Aortic Aneurysms and Suprarenal Aortic Aneurysms, sponsored by Gustavo S Oderich.
NCT01937949 is a NA study of Juxtarenal Aortic Aneurysms and Suprarenal Aortic Aneurysms that is actively recruiting participants, run by Gustavo S Oderich. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01937949, a NA study of Juxtarenal Aortic Aneurysms and Suprarenal Aortic Aneurysms, is actively recruiting participants, sponsored by Gustavo S Oderich.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate clinical outcomes and quality of life measures in treated by endovascular aortic repair of juxtarenal, suprarenal, and type IV thoracoabdominal aortic aneurysms using custom-made Cook Zenith® Fenestrated AAA Endovascular Graft.
Primary Outcome
Deaths 30 days after treatment
Conditions Studied
Interventions
- DEVICE Custom-made Zenith® Fenestrated AAA Endovascular Graft:
Study Locations (2)
Minnesota
- Mayo Clinic - Rochester
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2013-08 |
| Est. Completion | 2030-05 |
| Phase | NA |
What NCT01937949 shows while recruiting
NCT01937949 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Juxtarenal Aortic Aneurysms appearing as the primary indexed condition, and to 1 intervention - of which Custom-made Zenith® Fenestrated AAA Endovascular Graft: is the first listed.
NCT01937949 reports a single indexed study location in Minnesota, Texas.
Frequently Asked Questions
What is clinical trial NCT01937949 about?
NCT01937949 is a clinical study titled "Complex Abdominal Aortic Aneurysm Repair With Fenestrated Stent Grafts". The purpose of this study is to evaluate clinical outcomes and quality of life measures in treated by endovascular aortic repair of juxtarenal, suprarenal, and type IV thoracoabdominal aortic aneurysms using custom-made Cook Zenith® Fenestrated AAA Endovascular Graft.
What is the current status of trial NCT01937949?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2013-08. Estimated completion is 2030-05.
What conditions does trial NCT01937949 study?
This clinical trial studies the following conditions: Juxtarenal Aortic Aneurysms, Suprarenal Aortic Aneurysms, Type IV Thoracoabdominal Aortic Aneurysms.
What interventions are being tested in trial NCT01937949?
The interventions under investigation include: Custom-made Zenith® Fenestrated AAA Endovascular Graft: (DEVICE).
Who is sponsoring clinical trial NCT01937949?
This trial is sponsored by Gustavo S Oderich, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01937949 being conducted?
This trial has 2 study locations across Minnesota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01937949's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia